Literature DB >> 19167678

Activated notch supports development of cytokine producing NK cells which are hyporesponsive and fail to acquire NK cell effector functions.

Veronika Bachanova1, Valarie McCullar, Todd Lenvik, Rosanna Wangen, Karen A Peterson, Dave E M Ankarlo, Angela Panoskaltsis-Mortari, John E Wagner, Jeffrey S Miller.   

Abstract

Natural Killer (NK) cells are powerful effectors of cytotoxicity against "stressed" cells. They also produce cytokines and chemokines to activate the adaptive immune response. Understanding NK cell development and maturation may have implications for cancer therapy and for immunity against infections. We hypothesized that Notch signaling, critical for hematopoesis, would be involved in NK cell development. The role of constitutively activated Notch1 (ICN) on NK cell maturation was studied using human umbilical cord blood (UCB) progenitors cultured on a murine embryonic liver stroma cell line (EL08-1D2) and human cytokines. UCB CD34(+)/ICN(+) sorted cells resulted in a population of CD7(+) early lymphoid precursors and subsequent NK lineage commitment independent of stroma or IL-15. Early expression of L-selectin on ICN(+) precursors suggested their homing competence. These precursors further committed to the NK lineage, and were capable of producing cytokines and chemokines such as interleukin (IL)-13, granulocyte macrophage-colony stimulating factor (GM-CSF), tumor necrosis factor-alpha (TNF-alpha), yet poorly acquired NK inhibitory receptors and cytotoxic effector function. In the presence of stroma, ICN(+) precursors also gave rise to a population of early T lineage committed cells characterized by expression of cytoplasmic CD3 gamma, epsilon, and delta chains, RAG1/2, and production of IL-2, suggesting bona fide Th1 commitment. Importantly, signals from EL08-1D2 stroma were required for this development process. In conclusion, sustained Notch signaling can replace stroma in differentiation of a common CD7(+) lymphoid precursor from UCB CD34(+) progenitors and induce NK cell commitment. However, these NK cells are immature in their cytokine production profile, are hyporesponsive, and poorly acquire NK cell receptors involved in self-tolerance and effector function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19167678      PMCID: PMC2655654          DOI: 10.1016/j.bbmt.2008.11.031

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  50 in total

1.  Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome.

Authors:  Sebastian Stier; Tao Cheng; David Dombkowski; Nadia Carlesso; David T Scadden
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

Review 2.  Notch pathway: making sense of suppressor of hairless.

Authors:  S Bray; M Furriols
Journal:  Curr Biol       Date:  2001-03-20       Impact factor: 10.834

3.  Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2.

Authors:  J S Miller; V McCullar
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

Review 4.  The biology of human natural killer-cell subsets.

Authors:  M A Cooper; T A Fehniger; M A Caligiuri
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

5.  The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells.

Authors:  K Ohishi; B Varnum-Finney; R E Serda; C Anasetti; I D Bernstein
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

6.  Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1.

Authors:  J C Aster; L Xu; F G Karnell; V Patriub; J C Pui; W S Pear
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

7.  Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.

Authors:  M A Cooper; T A Fehniger; S C Turner; K S Chen; B A Ghaheri; T Ghayur; W E Carson; M A Caligiuri
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

8.  Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells.

Authors:  Matthew J Loza; Loris Zamai; Livio Azzoni; Emanuela Rosati; Bice Perussia
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

9.  Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors.

Authors:  Sophie M Lehar; James Dooley; Andrew G Farr; Michael J Bevan
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

10.  Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation.

Authors:  A C Jaleco; H Neves; E Hooijberg; P Gameiro; N Clode; M Haury; D Henrique; L Parreira
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

View more
  16 in total

1.  Multiple Levels of Control Determine How E4bp4/Nfil3 Regulates NK Cell Development.

Authors:  Tomasz Kostrzewski; Aaron J Borg; Yiran Meng; Iva Filipovic; Victoria Male; Andreas Wack; Peter A DiMaggio; Hugh J M Brady
Journal:  J Immunol       Date:  2018-01-08       Impact factor: 5.422

2.  Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue.

Authors:  Qin Tang; Yong-Oon Ahn; Peter Southern; Bruce R Blazar; Jeffery S Miller; Michael R Verneris
Journal:  Blood       Date:  2011-02-10       Impact factor: 22.113

3.  The Notch ligands Jagged2, Delta1, and Delta4 induce differentiation and expansion of functional human NK cells from CD34+ cord blood hematopoietic progenitor cells.

Authors:  Rose C Beck; Mallika Padival; David Yeh; Justine Ralston; Kenneth R Cooke; John B Lowe
Journal:  Biol Blood Marrow Transplant       Date:  2009-09       Impact factor: 5.742

4.  Natural killer cell differentiation from hematopoietic stem cells: a comparative analysis of heparin- and stromal cell-supported methods.

Authors:  Steven A Dezell; Yong-Oon Ahn; Jan Spanholtz; Hongbo Wang; Matthew Weeres; Scott Jackson; Sarah Cooley; Harry Dolstra; Jeffrey S Miller; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-07       Impact factor: 5.742

5.  Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling.

Authors:  Frank Cichocki; Martin Felices; Valarie McCullar; Steven R Presnell; Ahmad Al-Attar; Charles T Lutz; Jeffrey S Miller
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

6.  Notch signaling defects in NK cells in patients with cancer.

Authors:  Gulnur K Zakiryanova; Elena Kustova; Nataliya T Urazalieva; Emile T Baimukhametov; Valeriy A Makarov; Gulmariya M Turaly; Galina V Shurin; Zarema M Biyasheva; Narymzhan N Nakisbekov; Michael R Shurin
Journal:  Cancer Immunol Immunother       Date:  2020-10-21       Impact factor: 6.968

7.  Notch signaling at later stages of NK cell development enhances KIR expression and functional maturation.

Authors:  Martin Felices; Dave E M Ankarlo; Todd R Lenvik; Heather H Nelson; Bruce R Blazar; Michael R Verneris; Jeffrey S Miller
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

8.  Notch Regulates Innate Lymphoid Cell Plasticity during Human NK Cell Development.

Authors:  Ansel P Nalin; Jesse J Kowalski; Alexander C Sprague; Blaire K Schumacher; Adam G Gerhardt; Youssef Youssef; Kiran V Vedantam; Xiaoli Zhang; Christian W Siebel; Emily M Mace; Michael A Caligiuri; Bethany L Mundy-Bosse; Aharon G Freud
Journal:  J Immunol       Date:  2020-10-05       Impact factor: 5.422

Review 9.  MicroRNA function in NK-cell biology.

Authors:  Aimee M Beaulieu; Natalie A Bezman; Jang Eun Lee; Mehrdad Matloubian; Joseph C Sun; Lewis L Lanier
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

10.  Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors.

Authors:  Seishi Kyoizumi; Yoshiko Kubo; Junko Kajimura; Kengo Yoshida; Tomonori Hayashi; Kei Nakachi; Malcolm A Moore; Marcel R M van den Brink; Yoichiro Kusunoki
Journal:  J Immunol       Date:  2017-09-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.